![](https://nthumb.tpgimages.com/mid2_com_img/1339/29472/TOP27682563.jpg)
Dibekacin drug molecule. Ball-and-stick molecular model of dibekacin, an aminoglycoside antibiotic developed in Japan. It is a derivative of another antibiotic, kanamycin, and is often used in combination with sulbenicillin. It is used to treat infections caused by kanamycin-resistant bacteria via protein synthesis inhibition. Its chemical formula is C18H37N5O8. Atoms are represented as spheres with conventional colour coding: hydrogen (white), carbon (black), oxygen (red), and nitrogen (blue).
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP27682563
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
biologybiologicalmedicinemedicalhealthcarenooneno-onenoonenobodycolour-codedballandstickmodelball-and-stickmodelmolecularmodelmolecularmoleculestructureatomsdrugdrugmolecule3d3dimensionalthreedimensionalchemicalchemistrydigitallygeneratedillustrationartworkmedicationpharmapharmaceuticalpharmacologypharmacologicaltherapytreatmentblackbackgroundcutoutcut-outantibioticbacteriabacterialinfectionsdibekacinjapanesejapankanamycinkanamycin-derivedkanamycin-resistantbacteriaantibioticresistanceantimicrobialresistanceamrantibioticresistantsulbenicillinaminoglycosideaminoglycosideantibioticproteinsynthesisinhibitionproteinsynthesisinhibitor
33daminoglycosideaminoglycosideamrandantibioticantibioticantibioticantibioticantimicrobialartworkatomsbackgroundbacteriabacteriabacterialballball-and-stickbiologicalbiologyblackchemicalchemistrycolour-codedcut-outcutoutdibekacindigitallydimensionaldimensionaldrugdruggeneratedhealthcareillustrationinfectionsinhibitioninhibitorjapanjapanesekanamycinkanamycin-derivedkanamycin-resistantmedicalmedicationmedicinemodelmodelmodelmolecularmolecularmoleculemoleculenono-onenobodynooneonepharmapharmaceuticalpharmacologicalpharmacologyproteinproteinresistanceresistanceresistantstickstructuresulbenicillinsynthesissynthesistherapythreetreatment